Cargando…
AIMing 2 treat atherosclerosis
The AIM2 inflammasome is activated by host and pathogen DNA. Work from the past 5 years indicates that the AIM2 inflammasome has an important role in advanced atherosclerosis driven by clonal haematopoiesis and possibly in atherosclerosis accelerated by acute infection. Therefore, the AIM2 inflammas...
Autores principales: | Soehnlein, Oliver, Tall, Alan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315844/ https://www.ncbi.nlm.nih.gov/pubmed/35882998 http://dx.doi.org/10.1038/s41569-022-00755-0 |
Ejemplares similares
-
Long COVID: aiming for a consensus
por: Munblit, Daniel, et al.
Publicado: (2022) -
A role for lipophagy in atherosclerosis
por: Laval, Thomas, et al.
Publicado: (2023) -
Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more?
por: LaCasse, Eric C.
Publicado: (2020) -
Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018) -
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
por: Soehnlein, Oliver, et al.
Publicado: (2021)